6110 POSTER Combination Chemotherapy With Capecitabine (C), Irinotecan (I) Oxaliplatin (O) and Bevacizumab (B) (XELOXIRIA) as First Line Treatment of Metastatic Colorectal Cancer (MCRC) – Preliminary Results of a Phase l-ll Trial

✍ Scribed by Bazarbashi, S.; Aljubran, A.; Soudy, H.; Alzahrani, A.; Darwish, A.; Eltaigani, A.; Nabil-Ahmed, M.; Edesa, W.; Shoukri, M.

• Book ID: 122387512
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 41 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71755-5